Simon Read

DNTH

Simon Read serves as director at Dianthus Therapeutics, Inc. (DNTH). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$630.8K

Net Position

Net Seller

$630.8K

Companies Traded

DNTH

Active Period

Aug 2026

2 total trades

Most Recent

Sell DNTH

Aug 19, 2026 · $326.6K

Simon Read's Insider Trading at Dianthus Therapeutics, Inc. (DNTH)

Buys

0 · $0.00

Sells

2 · $630.8K

Total Shares Bought

Total Shares Sold

5,555

DNTH Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 19, 2026	Sell	2,778	$117.55	$326.6K	0
Aug 11, 2026	Sell	2,777	$109.55	$304.2K	2,707

Related Insiders

Simrat Randhawa

officer: EVP, Head of R&D

DNTHSell · Sep 3, 2026

Anne McGeorge

director

DNTHSell · Aug 11, 2026

Adam M Veness

officer: SVP, General Counsel and Sec.

DNTHSell · Aug 11, 2026

Marino Garcia

director, officer: CEO AND PRESIDENT

DNTHSell · Aug 7, 2026

Ryan Savitz

officer: EVP, CFO & CBO

DNTHSell · Jul 13, 2026

Paula Soteropoulos

director

DNTHSell · May 11, 2026

CARR EDWARD

officer: CHIEF ACCOUNTING OFFICER

DNTHSell · Mar 13, 2026

Explore More Insider Trading Data

DNTH Insider Trading Activity

View all insider trades at Dianthus Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity